Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

"More Than an Ebola Stock"

Two headlines I saw yesterday really capture the risk investors face when they attempt to chase gains based on the escalating Ebola crisis.

The first headline, in the International Business Times, told us that "Experimental Ebola Drug-Maker Chimerix Stock Falls After Dallas Ebola Patient Dies."

Full Story

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK